{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:45:11Z","timestamp":1792676711117,"version":"4.5.0"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/crd.0000000000000066","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T10:56:15Z","timestamp":1427280975000},"page":"182-188","source":"Crossref","is-referenced-by-count":16,"title":["Cardiac Transplantation in the New Era"],"prefix":"10.1097","volume":"23","author":[{"given":"Alan L.","family":"Gass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Emaminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhaya","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Spielvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Malekan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lansman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.healun.2009.08.002","article-title":"Registry of the international society for heart and lung transplantation: twelfth official pediatric lung and heartlung transplantation report-2009.","volume":"28","author":"Aurora","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.healun.2009.08.014","article-title":"Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report-2009.","volume":"28","author":"Taylor","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1053-2498(99)00075-3","article-title":"New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing.","volume":"18","author":"Renlund","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.healun.2009.01.006","article-title":"Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.","volume":"28","author":"Raichlin","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archsurg.1933.01170020053003","article-title":"Transplantation of the intact mammalian heart.","volume":"26","author":"Mann","year":"1933","journal-title":"Arch Surg"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/0003-4975(94)90496-0","article-title":"A surgeon to remember: notes about Vladimir Demikhov.","volume":"58","author":"Shumacker","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"R15-5-20210203","first-page":"127","article-title":"Studies in homologous canine heart transplantation: prolongation of survival with a folic acid antagonist.","volume":"52","author":"Reemtsma","year":"1962","journal-title":"Surgery"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0002-9149(68)90173-2","article-title":"Transplantation of the heart in an infant and an adult.","volume":"22","author":"Kantrowitz","year":"1968","journal-title":"Am J Cardiol"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9149(68)90174-4","article-title":"Initial clinical experience with heart transplantation.","volume":"22","author":"Stinson","year":"1968","journal-title":"Am J Cardiol"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0022-5223(99)70438-1","article-title":"Orthotopic cardiac transplantation after minimally invasive direct coronary artery bypass.","volume":"117","author":"Reardon","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R23-5-20210203","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006.","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0003-4975(03)01070-1","article-title":"Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis.","volume":"76","author":"Morgan","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.healun.2007.11.566","article-title":"Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.","volume":"27","author":"Weiss","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.athoracsur.2008.02.015","article-title":"Impact of recipients age on heart transplantation outcome.","volume":"85","author":"Tjang","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R29-5-20210203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.healun.2008.05.006","article-title":"Long-term outcomes of heart transplantation in older recipients.","volume":"27","author":"Marelli","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jacc.2008.08.070","article-title":"The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.","volume":"53","author":"Patlolla","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0002-8703(93)90704-D","article-title":"Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience.","volume":"126","author":"Murali","year":"1993","journal-title":"Am Heart J"},{"key":"R32-5-20210203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality.","volume":"114","author":"Chen","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-5-20210203","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/euhj.1998.1155","article-title":"High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate.","volume":"20","author":"Lindelow","year":"1999","journal-title":"Eur Heart J"},{"key":"R34-5-20210203","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","article-title":"Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.","volume":"83","author":"Etz","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R35-5-20210203","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejcts.2006.12.036","article-title":"Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.","volume":"31","author":"Zimpfer","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"R36-5-20210203","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/CIRCULATIONAHA.106.615708","article-title":"Columbia University Heart Transplant Outcomes Research Group. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database.","volume":"114","author":"Russo","year":"2006","journal-title":"Circulation"},{"key":"R37-5-20210203","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007890-199710270-00008","article-title":"Simultaneous heart and kidney transplantation as treatment for end-stage heart and kidney failure.","volume":"64","author":"Laufer","year":"1997","journal-title":"Transplantation"},{"key":"R38-5-20210203","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.transproceed.2011.08.095","article-title":"Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone.","volume":"43","author":"Czer","year":"2011","journal-title":"Transplant Proc"},{"key":"R39-5-20210203","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.transproceed.2011.01.190","article-title":"Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy.","volume":"43","author":"Raichlin","year":"2011","journal-title":"Transplant Proc"},{"key":"R40-5-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0031-1299574","article-title":"Renal graft outcome in combined heart-kidney transplantation compared to kidney transplantation alone: a single-center, matched-control study.","volume":"60","author":"Kebschull","year":"2012","journal-title":"Thorac Cardiovasc Surg"},{"key":"R41-5-20210203","first-page":"2446","article-title":"Long-term results of simultaneous multiple-organ transplants.","volume":"27","author":"Busson","year":"1995","journal-title":"Transplant Proc"},{"key":"R42-5-20210203","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1010-7940(97)00225-X","article-title":"Combined heart and kidney transplantation: an effective therapeutic option-report of six cases.","volume":"12","author":"Colucci","year":"1997","journal-title":"Eur J Cardiothorac Surg"},{"key":"R43-5-20210203","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.healun.2011.06.003","article-title":"Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity.","volume":"30","author":"Lee","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R44-5-20210203","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.","volume":"331","author":"Bjoro","year":"1994","journal-title":"N Engl J Med"},{"key":"R45-5-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(95)90583-9","article-title":"A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.","volume":"345","author":"Pereira","year":"1995","journal-title":"Lancet"},{"key":"R46-5-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"R47-5-20210203","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1053-2498(00)00198-4","article-title":"Outcome of heart transplantation in patients previously infected with hepatitis C virus.","volume":"20","author":"Castella","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R49-5-20210203","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2011.03.004","article-title":"Human immunodeficiency virus infection and left ventricular assist devices: a case series.","volume":"30","author":"Sims","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R50-5-20210203","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1007\/s00330-014-3246-2","article-title":"Assessment of sub-clinical acute cellular rejection after heart transplantation: comparison of cardiac magnetic resonance imaging and endomyocardial biopsy.","volume":"24","author":"Krieghoff","year":"2014","journal-title":"Eur Radiol"},{"key":"R52-5-20210203","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","article-title":"International Society for Heart and Lung Transplantation. The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report-2013; focus theme: age.","volume":"32","author":"Lund","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R54-5-20210203","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R55-5-20210203","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"R57-5-20210203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"International Society for Heart and Lung Transplantation. Acute antibody-mediated rejection of cardiac transplants.","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R58-5-20210203","first-page":"127","article-title":"Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients.","volume":"6","author":"Herskowitz","year":"1987","journal-title":"J Heart Transplant"},{"key":"R59-5-20210203","first-page":"430","article-title":"Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.","volume":"8","author":"Hammond","year":"1989","journal-title":"J Heart Transplant"},{"key":"R60-5-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1053-2498(02)00472-2","article-title":"Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.","volume":"22","author":"Michaels","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R61-5-20210203","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healun.2009.01.015","article-title":"Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.","volume":"28","author":"Wu","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R62-5-20210203","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1600-6143.2007.01900.x","article-title":"Acute antibody-mediated rejection following heart transplantation.","volume":"7","author":"Uber","year":"2007","journal-title":"Am J Transplant"},{"key":"R63-5-20210203","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"key":"R64-5-20210203","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation.","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"R65-5-20210203","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.healun.2004.07.021","article-title":"C4d deposition in cardiac allografts correlates with alloantibody.","volume":"24","author":"Smith","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R67-5-20210203","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","article-title":"International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012.","volume":"31","author":"Stehlik","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R68-5-20210203","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.healun.2011.08.005","article-title":"The registry of the international society for heart and lung transplantation: fourteenth pediatric heart transplantation report-2011.","volume":"30","author":"Kirk","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R70-5-20210203","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1053-2498(00)00095-4","article-title":"Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.","volume":"19","author":"Taylor","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R71-5-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Consensus Conference Participants. Report from a consensus conference on antibody-mediated rejection in heart transplantation.","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R72-5-20210203","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.healun.2011.02.002","article-title":"Current and future challenges in therapy for antibody-mediated rejection.","volume":"30","author":"Nair","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R73-5-20210203","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ccd.22975","article-title":"Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature.","volume":"77","author":"Dasari","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R75-5-20210203","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.healun.2006.05.002","article-title":"International Society for Heart and Lung Transplantation. Registry of the international society for heart and lung transplantation: twenty-third official adult heart transplantation report-2006.","volume":"25","author":"Taylor","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R76-5-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jchf.2014.01.003","article-title":"Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.","volume":"2","author":"Agarwal","year":"2014","journal-title":"JACC Heart Fail"},{"key":"R77-5-20210203","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.transproceed.2010.03.065","article-title":"Percutaneous coronary interventions in cardiac allograft vasculopathy: a single-center experience.","volume":"42","author":"Colombo","year":"2010","journal-title":"Transplant Proc"},{"key":"R78-5-20210203","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCULATIONAHA.106.647149","article-title":"Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies.","volume":"116","author":"Hiemann","year":"2007","journal-title":"Circulation"},{"key":"R79-5-20210203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.RES.0000246086.93555.f3","article-title":"Allograft vasculopathy versus atherosclerosis.","volume":"99","author":"Rahmani","year":"2006","journal-title":"Circ Res"},{"key":"R80-5-20210203","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","article-title":"Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression.","volume":"4","author":"Caforio","year":"2004","journal-title":"Am J Transplant"},{"key":"R82-5-20210203","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/hc3101.093867","article-title":"Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study.","volume":"104","author":"Tsutsui","year":"2001","journal-title":"Circulation"},{"key":"R86-5-20210203","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.2741\/2903","article-title":"Mechanisms of chronic rejection in cardiothoracic transplantation.","volume":"13","author":"Weiss","year":"2008","journal-title":"Front Biosci"},{"key":"R88-5-20210203","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.TP.0000119722.37337.DC","article-title":"Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.","volume":"77","author":"Bonaros","year":"2004","journal-title":"Transplantation"},{"key":"R89-5-20210203","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/01.TP.0000090163.48433.48","article-title":"Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy.","volume":"76","author":"Fateh-Moghadam","year":"2003","journal-title":"Transplantation"},{"key":"R90-5-20210203","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/j.1600-6143.2009.02801.x","article-title":"Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.","volume":"9","author":"Graham","year":"2009","journal-title":"Am J Transplant"},{"key":"R92-5-20210203","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/ATVBAHA.114.302818","article-title":"Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.","volume":"34","author":"Pober","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R93-5-20210203","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation.","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"R94-5-20210203","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0735-1097(01)01430-9","article-title":"Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation.","volume":"38","author":"Weis","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R95-5-20210203","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jacc.2003.08.063","article-title":"Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease.","volume":"43","author":"Kato","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R96-5-20210203","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1189\/jlb.0607339","article-title":"Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.","volume":"83","author":"Leong","year":"2008","journal-title":"J Leukoc Biol"},{"key":"R97-5-20210203","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.0000087604.27270.5B","article-title":"Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient.","volume":"108","author":"Yamani","year":"2003","journal-title":"Circulation"},{"key":"R98-5-20210203","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0735-1097(96)00521-9","article-title":"Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease.","volume":"29","author":"Gao","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R99-5-20210203","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jacc.2003.08.059","article-title":"The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.","volume":"43","author":"Mehra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R100-5-20210203","first-page":"791","article-title":"Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.","volume":"138","author":"Salomon","year":"1991","journal-title":"Am J Pathol"},{"key":"R101-5-20210203","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0735-1097(10)80114-7","article-title":"Transplant coronary artery disease: histopathologic correlations with angiographic morphology.","volume":"17","author":"Johnson","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"R103-5-20210203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.TP.0000071200.37399.1D","article-title":"Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.","volume":"76","author":"Sharples","year":"2003","journal-title":"Transplantation"},{"key":"R106-5-20210203","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/hrt.2007.119693","article-title":"Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients.","volume":"94","author":"Eroglu","year":"2008","journal-title":"Heart"},{"key":"R107-5-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.100.5.509","article-title":"Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound.","volume":"100","author":"Spes","year":"1999","journal-title":"Circulation"},{"key":"R108-5-20210203","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/CRD.0b013e3181fbde2f","article-title":"Cardiac allograft vasculopathy: advances in diagnosis.","volume":"19","author":"Cai","year":"2011","journal-title":"Cardiol Rev"},{"key":"R109-5-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/eurheartj\/14.1.48","article-title":"High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation.","volume":"14","author":"Ciliberto","year":"1993","journal-title":"Eur Heart J"},{"key":"R110-5-20210203","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0735-1097(95)00084-H","article-title":"Dobutamine stress echocardiography in orthotopic heart transplant recipients. VACOMED Research Group.","volume":"25","author":"Derumeaux","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R111-5-20210203","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1053-2498(02)00444-8","article-title":"Relationship between dobutamine-induced regional wall motion abnormalities and coronary flow reserve in heart transplant patients without angiographic coronary artery disease.","volume":"21","author":"Jackson","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R112-5-20210203","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1053-2498(00)00167-4","article-title":"Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients.","volume":"19","author":"Carlsen","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R114-5-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/TP.0b013e318195a5a7","article-title":"Dual-source CT coronary angiogram in heart transplant recipients in comparison with dobutamine stress echocardiography for detection of cardiac allograft vasculopathy.","volume":"87","author":"Mastrobuoni","year":"2009","journal-title":"Transplantation"},{"key":"R115-5-20210203","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.healun.2006.06.018","article-title":"Detection of coronary artery disease in orthotopic heart transplant recipients with 64-detector row computed tomography angiography.","volume":"25","author":"Iyengar","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R116-5-20210203","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0735-1097(03)00924-0","article-title":"Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging.","volume":"42","author":"Muehling","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R117-5-20210203","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(02)11473-5","article-title":"C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study.","volume":"360","author":"Labarrere","year":"2002","journal-title":"Lancet"},{"key":"R118-5-20210203","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jama.284.4.457","article-title":"Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation.","volume":"284","author":"Labarrere","year":"2000","journal-title":"JAMA"},{"key":"R120-5-20210203","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00059-005-2685-6","article-title":"Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.","volume":"30","author":"Wenke","year":"2005","journal-title":"Herz"},{"key":"R121-5-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0162-3109(96)00108-7","article-title":"Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.","volume":"34","author":"Kurakata","year":"1996","journal-title":"Immunopharmacology"},{"key":"R122-5-20210203","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator.","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"R123-5-20210203","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9149(99)80432-9","article-title":"An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.","volume":"75","author":"Mehra","year":"1995","journal-title":"Am J Cardiol"},{"key":"R124-5-20210203","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199301213280303","article-title":"A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.","volume":"328","author":"Schroeder","year":"1993","journal-title":"N Engl J Med"},{"key":"R125-5-20210203","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/01.TP.0000131148.78203.B7","article-title":"Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation.","volume":"77","author":"Steinhauff","year":"2004","journal-title":"Transplantation"},{"key":"R126-5-20210203","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.healun.2004.06.005","article-title":"The effect of combined angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.","volume":"24","author":"Erinc","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R129-5-20210203","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients-a large European trial.","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transplant"},{"key":"R130-5-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Study Investigators. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"R131-5-20210203","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.healun.2006.01.003","article-title":"Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil.","volume":"25","author":"Kaczmarek","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R132-5-20210203","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"R134-5-20210203","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Mycophenolate Mofetil Cardiac Study Investigators. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R135-5-20210203","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"R136-5-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy.","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"R137-5-20210203","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"R141-5-20210203","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1053-2498(02)00413-8","article-title":"Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One centers experience.","volume":"21","author":"Aranda","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R142-5-20210203","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2004.02.045","article-title":"Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience.","volume":"43","author":"Benza","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R143-5-20210203","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.healun.2004.10.005","article-title":"Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy.","volume":"24","author":"Simpson","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R144-5-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/14.1.65","article-title":"Coronary angioplasty in cardiac transplant recipients.","volume":"14","author":"Swan","year":"1993","journal-title":"Eur Heart J"},{"key":"R146-5-20210203","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0735-1097(98)00432-X","article-title":"Coronary stenting in cardiac allograft vasculopathy.","volume":"32","author":"Jain","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R147-5-20210203","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1053-2498(00)00115-7","article-title":"The role of percutaneous transluminal coronary angioplasty in heart transplant recipients.","volume":"19","author":"Schnetzler","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R148-5-20210203","first-page":"1936","article-title":"The role of PTCA in the management of focal critical lesions in transplant coronary artery disease.","volume":"27","author":"von Scheidt","year":"1995","journal-title":"Transplant Proc"},{"key":"R149-5-20210203","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0041-1345(00)00818-6","article-title":"Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation.","volume":"32","author":"Redonnet","year":"2000","journal-title":"Transplant Proc"},{"key":"R151-5-20210203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1010-7940(97)01167-6","article-title":"Revascularization procedures in patients with transplant coronary artery disease.","volume":"11","author":"Patel","year":"1997","journal-title":"Eur J Cardiothorac Surg"},{"key":"R152-5-20210203","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-2007-1010237","article-title":"Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease.","volume":"46","author":"Musci","year":"1998","journal-title":"Thorac Cardiovasc Surg"},{"key":"R153-5-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007890-200008270-00013","article-title":"The results of cardiac retransplantation: an analysis of the joint international society for heart and lung transplantationUnited Network for Organ Sharing Thoracic Registry.","volume":"70","author":"Srivastava","year":"2000","journal-title":"Transplantation"},{"key":"R154-5-20210203","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.healun.2005.02.015","article-title":"A decade experience of cardiac retransplantation in adult recipients.","volume":"24","author":"Topkara","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:49:40Z","timestamp":1620949780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201507000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000066","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}